Genmab A/SGMABNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank14
3Y CAGR-56.6%
5Y CAGR-41.8%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

3Y CAGR
-56.6%/yr
vs +26.9%/yr prior
5Y CAGR
-41.8%/yr
Recent deceleration
Acceleration
-83.5pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
20255.92%
202426.42%
202312.02%
202272.33%
2021-16.75%
202088.43%
201977.38%
201827.89%
201730.25%
201660.29%